We isolated the full length provirus of human T cell leukaemia virus type I (HTLV-I) from MT-2, a lymphoid cell line producing HTLV-I. In three non-lymphoid cell lines (COS7, human osteosarcoma HOS cells, and HeLa) this provirus expressed a transacting activity after co-transfection with a recombinant plasmid carrying a bacterial chloramphenicol acetyltransferase gene under the control of a long terminal repeat of HTLV-I provirus. The trans-acting protein p40 was detected by immunoprecipitation in transfected HOS cells. Structural proteins of HTLV-I, the gag and env products, were also formed and processed in the same manner as observed in MT-2 cells. In transfected HeLa cells, the p40 protein was mainly localized in the nucleus, while other structural proteins were detected in the cytoplasm and/or the membrane by indirect immunofluorescence. Syncytium formation was observed in HeLa cells after transfection. These results demonstrated that non-lymphoid cells could produce the major proteins of HTLV-I after DNA transfection of the cloned provirus.
INTRODUCTION
Human T cell leukaemia virus type I (HTLV-I) is an exogenous virus associated with an endemic human T cell malignancy termed adult T cell leukaemia (ATL) (Poiesz et al., 1980; Hinuma et al., 1981 ; Yoshida et al., 1982; Kalyanaraman et al., 1982; Popovic et al., 1983) . Experimentally, human T cells can be productively infected, transformed and immortalized by co-cultivation with HTLV-I-producing cells derived from ATL patients Yamamoto et al., 1982) . HTLV-I can infect human cells other than T lymphocytes, such as osteosarcoma cells, B lymphocytes and endothelial cells Okada et al., 1984; Ho et al., 1984; Hoxie et al., 1984) but there is no evidence for transformation of these cells. Although the mechanism causing transformation of T cells by HTLV-I remains unknown, HTLV-I is unique in other respects. It has the unique pX sequence located between the env gene and the 3' long terminal repeat (LTR) (Seiki et al., 1983) . One of the pX open reading frames, termed tat, encodes a 40000 mol. wt. protein (p40) which is responsible for transcriptional transactivation from the LTR (Sodroski et al., 1984 (Sodroski et al., , 1985 Kiyokawa et al., 1984; Slamon et al., 1984 Slamon et al., , 1985 Miwa et al., 1984; Lee et al., 1984; Hatanaka & Kobayashi, 1985; Felber et al., 1985) . The trans-acting activity of p40 has been suggested to be related to HTLV-I leukaemogenesis, possibly by inducing the expression of some cellular genes in the infected cells (Sugamura et al., 1984; Sodroski et al., 1985; Chen et al., 1985; Hatanaka & Kobayashi, 1985) .
In the present study we isolated a full-length provirus of HTLV-I and examined its expression in cell lines by DNA transfection.
METHODS

Cells.
MT-2 cells were maintained in RPMI 1640 medium containing 10% foetal calf serum (FCS). COS7 (Gluzman, 1981) and HeLa cells were maintained in Dulbecco's modified Eagle's medium 0000-7327 © 1987 SGM (DMEM) containing 10~ FCS. HOS cells were maintained in Eagle's medium (MEM) containing 20~ FCS.
Transfections. The calcium phosphate precipitation method (Wigler et al., 1979) was used; generally, recipient cells were seeded into 100 mm culture dishes 24 h prior to transfection at a density of 3 x 105 cells per dish. A total of 20 vtg DNA was used for each transfection.
Chloramphenicol acetyltransferase (CA T) assay. At 48 h after transfection, cells were harvested, washed twice with phosphate-buffered saline (PBS), and then suspended in 100 I.tl of 250 mM-Tris-HCl pH 8.0. Cell extracts were prepared by three cycles of freezing (-70 °C) and thawing (37 °C ) followed by centrifugation to remove cellular debris. CAT activities were assayed according to Gorman et al. (1982) . To allow comparison of CAT activities between several transfections, the quantity of DNA transfected was standardized at 10 ~g of pSV2CAT or pHLC1, or 2 to 10 I~g HTLV-I provirus and 10 ~tg of pHLC1.
Antisera. Sera from Japanese ATL patients which reacted with HTLV-I env and gag products (gp61, gp46 and gp21, and p53, p24 and p19) were used Hattori et al., 1984) . A monoclonal antibody, MI73, was used which reacted with p40 and gp68, the latter being a product of a defective type provirus in MT-2 cells (Takeuchi et al., 1985) . A second monoclonal antibody, GIN-7, reacted with p19 and p28, the latter being a product of another defective type provirus in MT-2 cells (Kobayashi et al., 1984b; Iino et al., 1986) , and also with p53 (Tanaka et al., 1983) .
Labelling cells with [3H]leucine and immunoprecipitation.
At 48 h after transfection, 106 to 2 x 106 cells were incubated in leucine-free RPMI 1640 medium containing 10~ FCS and 1 mCi [3H]leucine (58 Ci/mmol, ICN Radiochemicals) for 8 h. Cell extracts were prepared by lysis in low salt extraction buffer [1.0 × 107 cells/ml; 10 mM-Tris-HC1 pH 8.0, 0.14 M-NaC1, 3 mM-MgC12, 0.5~ (w/v) NP40 (Nakarai Chemicals, Kyoto, Japan), 1 mM-dithiothreitol, 2 mM-PMSF] for 1 h at 4 °C. Cell lysates were clarified by centrifugation, then incubated overnight at 4 °C with the appropriate antiserum. Immune complexes were recovered by using Affi-Gel-Protein A (Bio-Rad) and analysed on 12~ polyacrylamide gels containing 0.1 ~ SDS as described previously (Iino et al., 1986) .
Indirect imrnunofluorescence assays. At 48 h after transfection, cells were fixed and then stained as follows, p40: cells were fixed in 3.7~ formaldehyde, made permeable with 0.1 ~ NP40 in PBS, treated with MI73 and then with FITC-conjugated anti-mouse IgG goat serum (Felber et al., 1985) . gag products and ATLA (ATL-associated antigens, mainly env and gag products; Kobayashi et al., 1984b) : cells were fixed in acetone and then treated with GIN-7 or an ATL patient's serum.
RESULTS
Isolation of a full length HTL V-I provirus DNA
We reported previously that MT-2 cells contain various HTLV-I proviruses, including defective and non-defective types (Kobayashi et al., 1984a) . We have cloned a non-defective provirus using apol fragment as a probe (Kobayashi et al., 1984a) . First, a genomic library was constructed from SacI-digested MT-2 genomic DNA using the ~gtWES3.B vector. One isolated clone, 2KM4-3, contained a full size HTLV-I provirus (Fig. 1 a) . We then reconstructed the provirus by adding LTR DNA fragments, which had been digested with EcoRI and SacI, to the cloned insert in the following order: U3R, insert DNA (gag-pol-env--tat) , RU5. The reconstructed provirus DNA was re-ligated to the 2gtWES2B vector at the EeoRI site (2HTLV1C) as shown in Fig. 1 (b) . For the DNA transfection experiments, the DNA of this recombinant phage was digested with EcoRI and its insert DNA was isolated by agarose gel electrophoresis.
Trans-acting activity in cells transfected with HTL V-I provirus DNA
We examined the expression of the trans-acting activity of the cloned HTLV-I provirus by DNA transfection. Two recombinant plasmids (Fig. 1 c) carrying the CAT gene were used to measure the CAT activity in the transfected cells. The CAT gene is regulated by the simian virus 40 (SV40) early promoter and transcription termination regions in pSV2CAT, and by the promoter region of the HTLV-I LTR in pHLC1. The latter plasmid was constructed by substituting the LTR for the SV40 early promoter region (Fig. 1 c) . The CAT activity in cells transfected by pSV2CAT or pHLC1 is expressed at a basal level depending on the promoter. These activities were used as references for calculating the trans-acting activity of the HTLV-I provirus introduced into cells (Table 1) , by normalizing against the CAT activity of pSV2CAT or pHLC1 (Table 1) (Gorman et al., 1982) . In pHLC1, the HTLV-I provirus LTR which is truncated at + 328 (cap + l) is substituted for the SV40 early promoter and enhancer region (H. Siomi et al., unpublished) . Arrows indicate the orientation of transcription and the site of transcription initiation. The restriction sites for AccI, SacI, EcoRI, and HindlII are shown as A, S, E and H respectively. Amp r, ampiciUin resistance. t The values indicate the ratio of the CAT activity of cells transfected with pHLC1 and HTLV-I provirus to that of cells transfected with pSV2CAT or pHLC1.
HeLa) transfected by the calcium phosphate precipitation method (Fig. 2, Table 1 ). While pSV2CAT expressed a high CAT activity in COS7 cells, the co-transfection of HTLV-I provirus and pHLC1 enhanced the activity in all the cell lines examined (Table 1) . The trans-acting activity in HTLV-I-transfected non-lymphoid cells was comparable to levels in the HTLV-Iproducing human T lymphoid cell line, MT-2 (data not shown). 
Immunoprecipitation analysis of HOS cells transfected with HTLV-I provirus DNA
Next, we tried to identify the trans-acting protein p40 in non-lymphoid cells transfected with HTLV-I provirus D N A . The transiently expressed gene products of HTLV-I in HOS cells were analysed by immunoprecipitation using various antibodies; immune complexes were analysed by S D S -P A G E . A band corresponding to p40 was detected in HOS cells transfected with the provirus and in MT-2 cells, but not in HOS cells transfected with pBR322 (Fig. 3a) . Therefore, these non-lymphoid cells produce p40.
Other gene products of HTLV-I were also analysed. The gag precursor protein p53 and the processed gag protein p 19 were identified by an anti-p 19 monoclonal antibody, though the ratios of p53 to p19 were different in transfected HOS cells and MT-2 cells (Fig. 3b) . Another gag protein, p24, was detected using an ATL patient's serum (Fig. 3c) . The env precursor protein gp61 and its processed proteins gp46 and gp21 were also identified (Fig. 3c) proteins of HTLV-I were formed and processed in HOS cells in a similar manner to that observed in MT-2 cells.
Microscopical and immunofluorescence observations on expression of H T L V-I provirus DNA in HeLa cells
We detected viral antigens in HeLa cells transfected with the HTLV-I provirus DNA by indirect immunofluorescence. The p40 was identified in the nuclear region as previously reported Felber et al., 1985) (Fig. 4a) . Less than 1 ~o of the transfected HeLa cells were stained, whereas all MT-2 cells were stained (data not shown). The gag products were visualized using a monoclonal antibody (Fig. 4 b) . Transfected HeLa cells were also stained with an ATL patient's serum that recognized mainly env and gag gene products (Fig. 4c) . No stained cells were detected in mock-transfected cells or in HTLV-I-transfected cells treated with myeloma culture fluid as controls (data not shown). Furthermore, we observed syncytia containing more than 10 nuclei 7 days after transfection of HeLa cells (Fig. 4d) . Addition of ATL patient serum to the transfected cells strongly inhibited syncytium formation (data not shown).
DISCUSSION
An HTLV-I provirus has been isolated from the leukaemic cells of an ATL patient and its sequence has been determined (Seiki et al., 1983) . However, there has been no report of a complete provirus capable of producing its own viral products or virus particles. Therefore, we isolated the full length provirus from the HTLV-I-producing cell line MT-2 and investigated its ability to form gene products in non-lymphoid cells. The results showed no significant difference in the production of tat, gag and env gene products between non-lymphoid cell lines and MT-2 cells. In addition, the trans-acting activity in non-lymphoid cells was significantly high. Processing of gag protein occurred in HOS cells, suggesting the expression of a protease gene like other retroviruses. In HeLa cells, we observed syncytium formation. Since this is known to be caused by the env gene product Hoshino et al., 1983; Hayami et al., 1984) , the result implies the transmission of the virus or the interaction of env gene products with neighbouring cells.
T lymphocyte-specific transformation by HTLV-I is an important phenomenon for understanding the relationship between HTLV-I and the T cell malignancy, ATL. There are several reports concerning the tissue specificity of HTLV-I infection or expression. First, no apparent tropism of HTLV-I for the cell surface receptors on T lymphocytes was observed using pseudotypes (Weiss et al., 1985) . Next, no tissue specificity of the enhancer element of the HTLV-I LTR was reported (Rosen et al., 1986) . Third, HTLV-I is known to form the transacting protein p40 responsible for its replication in HTLV-I-producing T lymphocytes . We have demonstrated that HTLV-I can express the tat gene in non-lymphoid cell lines following DN A transfection; the gag and env genes were also expressed simultaneously in these cell lines. Our results suggest that the expression of HTLV-I in non-lymphoid cells may occur in the same manner as in naturally transformed T lymphocytes. Although no difference was apparent between T lymphocytes and other cells in the expression of HTLV-I, there might be a specific function(s) of HTLV-I in T lymphocytes, for example the induction of a cellular
